Episode 2 of The AML Expert Series explores the evolving role of targeted therapies in R/R AML. Discover evidence-based strategies, current regimens, & key guideline updates to inform your practice. AML Expert Series, Ep 2 – Tune in now! #oncology #AML

Just launched! Access expert-led insights on DKA guidelines, pathophysiology, emerging technologies, and practical strategies to overcome real-world barriers. Register now and earn free CME credit

How can molecular testing be better integrated into AML care? In Episode 1 of The AML Expert Series, hear practical strategies to overcome barriers & apply testing insights to optimize patient outcomes. AML Expert Series, Ep 1 – Tune in now!  #AML #meded

Now live: The AML Expert Series - a 3-part podcast on molecular testing, IDH1/2 mutations, targeted therapies and personalized strategies in R/R AML - hosted by @ProfAmerZeidan with leading experts. Advance your practice in R/R AML – #oncology #meded

Access expert guidance on diagnosing and treating late-onset genetic cholestasis, with this interactive clinical pathway tool. Access here #LiverDisease #Hepatology #Gastroenterology

How well do you know CAR-T therapy for DLBCL? Following #EHA2025, we're putting your clinical insight to the test. You can find key updates and highlights at: What’s the biggest barrier to wider CAR-T use in DLBCL?.

Elevate patient care in aplastic anemia with individualized treatment strategies. Our latest module is designed to help you tailor management for special populations, through real-world scenarios and expert-led insights. Get started here. #aplasticanemia

Just launched! The AML expert series - a 3-part podcast series featuring expert insights on molecular testing, key genetic mutations, such as IDH1/2, targeted therapies, and personalized treatment strategies. Advance your practice in R/R AML – listen now

How well do you know CAR-T therapy for DLBCL?.Following #EHA2025, we're putting your clinical insight to the test. You can find key updates and highlights at: What is most needed to optimize CAR-T outcomes in DLBCL?.

Missed #ADA2025? Catch up on key updates. Program Director, Dr David Kerr (@GoDiabetesMD) unpacks emerging data on ketone monitoring and its real-world impact on DKA management. Tune in now to stay ahead #ADASciSessions #MedEd #DiabetesCare #DKA #CKM

How well do you know CAR-T therapy for DLBCL?.Following #EHA2025, we're putting your clinical insight to the test. You can find key updates and highlights at: Which factor do you consider most predictive of CAR-T therapy failure in patients with DLBCL?.

Just launched: an accredited 5-part video podcast series where expert faculty breakdown the evolving gMG treatment landscape - from emerging data to real-world strategies that enhance patient outcomes. Watch now and earn CME credits . #gMG #CME #MedEd

How well do you know CAR-T therapy for DLBCL?.Following #EHA2025, put your clinical insight to the test. If you missed the conference updates - find our key highlights at: What’s the key consideration in selecting DLBCL patients for CAR-T therapy?.

Watch a powerful 25-minute conversation between patient and clinician as they tackle CGM barriers, how to build patient confidence, and strengthen communication. Watch now and elevate your practice. #DiabetesCare #CGM #MedEd #CME

Read the meeting report that covers the key challenges faced by members of the multidisciplinary care team when utilizing biomarkers in Alzheimer’s disease. This content is intended for healthcare professionals outside of the UK

Dr Pim Mutsaers shares his thoughts on the ATLANTA-1 trial data on GLPG5101 in patients with R/R NHL at #EHA2025 . Watch the full interview now #Hematology #CARTcells #CAR_T #Oncology #CellTherapy #RRLymphoma #GLPG5101

Dr Eddie Cliff explores the evolving role of #CARTcell therapy in LBCL and shares key immunotherapy insights from #EHA2025 congress. Don’t miss his expert take - watch the full interview #Hematology #CARTcells #CAR_T #LBCL #Oncology #CellTherapy

Referencing the latest ATN framework and tailored to US practice, this accredited expert-led session offers practical tips on selecting, interpreting & reporting amyloid and tau biomarkers. Watch now: #MedEd #AlzheimersDisease #Biomarkers

This gMG Awareness Month, tune into our new accredited video podcast series highlighting the latest clinical breakthroughs, emerging data, and practical expert insights relating to important themes in gMG. Tune in now and earn CME credit #gMG #MedEd

To mark gMG Awareness Month, our new video podcast has launched! Ep 1 explores the fundamentals of adult and pediatric gMG - essential viewing for neurologists and clinicians managing patients throughout their #gMG journey. Tune in now and earn CME: